Citation Impact
Citing Papers
New approaches and procedures for cancer treatment: Current perspectives
2021 Standout
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
2009 Standout
RNAi-Based Approaches for Pancreatic Cancer Therapy
2021
Intestinal Transport of Irinotecan in Caco-2 Cells and MDCK II Cells Overexpressing Efflux Transporters Pgp, cMOAT, and MRP1
2002
Human Multidrug Resistance Associated Protein 4 Confers Resistance to Camptothecins
2005
Anti-proliferative effects of mesenchymal stem cells (MSCs) derived from multiple sources on ovarian cancer cell lines: an in-vitro experimental study
2019
Screening Libraries to Discover Molecular Design Principles for the Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers Derived from Plant Phenolic Acids
2023 StandoutNobel
Engineering precision nanoparticles for drug delivery
2020 Standout
Pharmacokinetics of prolonged-release CPT-11-loaded microspheres in rats
2000
Applications of novel drug delivery system for herbal formulations
2010 Standout
From traditional Chinese medicine to rational cancer therapy
2007 Standout
A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study1
2006
CLINICAL STUDIES OF CAMPTOTHECIN AND DERIVATIVES
2003
Multiplicity of biliary excretion mechanisms for the camptothecin derivative irinotecan (CPT-11), its metabolite SN-38, and its glucuronide: role of canalicular multispecific organic anion transporter and P-glycoprotein
1998
Phase 2 study of weekly irinotecan in adults with recurrent malignantglioma: Final report of NABTT 97-11
2004
Pharmacokinetic and pharmacodynamic evaluation of the topoisomerase inhibitor irinotecan in cancer patients.
1997
Multicentre phase II study and pharmacokinetic analysis of irinotecan in chemotherapy-naïve patients with glioblastoma
2003
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery
2021 StandoutNobel
Bioavailability enhancers of herbal origin: An overview
2013 Standout
Targeting multidrug resistance in cancer
2006 Standout
Gut microbiota modulation of chemotherapy efficacy and toxicity
2017 Standout
Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity
2002
Clinical applications of the camptothecins
1998
Medical management of patients with brain tumors
2006
Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of β-glucuronidase activity in intestinal lumen
2010
Malignant Gliomas in Adults
2008 Standout
A review of the pharmacology and clinical activity of new chemotherapy agents for the treatment of colorectal cancer
1999
Natural compounds for cancer treatment and prevention
2009 Standout
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
Herb-Drug Interactions
2005 Standout
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Bioinspired lipoproteins-mediated photothermia remodels tumor stroma to improve cancer cell accessibility of second nanoparticles
2019
Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins.
2002
The Unexpected Importance of the Primary Structure of the Hydrophobic Part of One-Component Ionizable Amphiphilic Janus Dendrimers in Targeted mRNA Delivery Activity
2022 StandoutNobel
Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans.
2000
Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).
2001
Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
2023 StandoutNobel
Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
2008 Standout
Lipids and Lipid Derivatives for RNA Delivery
2021
Mathematics – Key Technology for the Future
2008 Standout
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
2007 Standout
Plasma Protein Adsorption and Biological Identity of Systemically Administered Nanoparticles
2017
Works of Xiaolin Wang being referenced
Lipoprotein-biomimetic nanostructure enables efficient targeting delivery of siRNA to Ras-activated glioblastoma cells via macropinocytosis
2017
Modulation of glucuronidation of SN-38, the active metabolite of irinotecan, by valproic acid and phenobarbital
1997
Pharmacokinetic modulation of irinotecan and metabolites by cyclosporin A.
1996
IL-4Rα aptamer-liposome-CpG oligodeoxynucleotides suppress tumour growth by targeting the tumour microenvironment
2016